Andrea Bernini

Prof. Andrea Bernini

Department of Biotechnology, Chemistry and Pharmacy, Università di Siena, Siena, Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HSHuai-Dong Song
Huai-Dong Song
CTChang-Chun Tu
Chang-Chun Tu
GZGuo-Wei Zhang
Guo-Wei Zhang
SWSheng-Yue Wang
Sheng-Yue Wang
KZKui Zheng
Kui Zheng
GZGuoping Zhao
Guoping Zhao
The genomic sequences of severe acute respiratory syndrome coronaviruses from human and palm civet of the 2003/2004 outbreak in the city of Guangzhou, China, were nearly identical. Phylogenetic analysis suggested an independent viral invasion from animal to human in this new episode. Combining all existing data but excluding singletons, we identified 202 single-nucleotide variations. Among them, 17 are polymorphic in palm civets only. The ratio of nonsynonymous/synonymous nucleotide substitution in palm civets collected 1 yr apart from different geographic locations is very high, suggesting a rapid evolving process of viral proteins in civet as well, much like their adaptation in the human host in the early 2002–2003 epidemic. Major genetic variations in some critical genes, particularly the Spike gene, seemed essential for the transition from animal-to-human transmission to human-to-human transmission, which eventually caused the first severe acute respiratory syndrome outbreak of 2002/2003.

1 March 2007 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
Chiara FalcianiChiara Falciani
Chiara Falciani
LLLuisa Lozzi
Luisa Lozzi
Alessandro PiniAlessandro Pini
Alessandro Pini
FCFederico Corti
Federico Corti
MFMonica Fabbrini
Monica Fabbrini
Luisa BracciLuisa Bracci
Luisa Bracci

8 February 2019 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
DADavid Ascher
David Ascher
OSOttavia Spiga
Ottavia Spiga
MSMartina Sekelska
Martina Sekelska
DPDouglas E. V. Pires
Douglas E. V. Pires
Andrea BerniniAndrea Bernini
Andrea Bernini
AZAndrea Zatkova
Andrea Zatkova

1 October 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
OSOttavia Spiga
Ottavia Spiga
Andrea BerniniAndrea Bernini
Andrea Bernini
ACArianna Ciutti
Arianna Ciutti
SCStefano Chiellini
Stefano Chiellini
NMNicola Menciassi
Nicola Menciassi
NNNeri Niccolai
Neri Niccolai

1 April 2005 in Antiviral Therapy
Verified
Journal Article
Closed access
BZBo-Jian Zheng
Bo-Jian Zheng
YGYi Guan
Yi Guan
Ming-Liang HeMing-Liang He
Ming-Liang He
HSHongzhe Sun
Hongzhe Sun
LDLanying Du
Lanying Du
JHJian-Dong Huang
Jian-Dong Huang
A novel severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) has been identified as the aetiological agent of SARS. We previously isolated and characterized SARS-CoV and SARS-CoV-like viruses from human and animals, respectively, suggesting that SARS could be transmitted from wild/farmed animals to humans. Comparison of the viral genomes indicated that sequence variation between animal and human isolates existed mainly in the spike (S) gene. We hypothesized that these variations may underlie a change of binding specificity of the S protein to the host cells, permitting viral transmission from animals to humans. Here we report that four 20-mer synthetic peptides (S protein fragments), designed to span these sequence variation otspots, exhibited significant antiviral activities in a cell line. SARS-CoV infectivity was reduced over 10 000-fold through pre-incubation with two of these peptides, while it was completely inhibited in the presence of three peptides. Molecular modelling of the SARS-CoV peplomer suggests that three of these antiviral peptides map to the interfaces between the three monomers of the trimeric peplomer rather than the heptad repeat region from which short peptides are known to inhibit viral entry. Our results revealed novel regions in the spike protein that can be targeted to inhibit viral infection. The peptides identified in this study could be further developed into antiviral drugs.

1 August 2001 in Protein Science
Verified
Journal Article
Open access
PDF file
NNNeri Niccolai
Neri Niccolai
RSRoberta Spadaccini
Roberta Spadaccini
MSMaria Scarselli
Maria Scarselli
Andrea BerniniAndrea Bernini
Andrea Bernini
OCOrlando Crescenzi
Orlando Crescenzi
PTPiero A. Temussi
Piero A. Temussi
The design of safe sweeteners is very important for people who are affected by diabetes, hyperlipemia, and caries and other diseases that are linked to the consumption of sugars. Sweet proteins, which are found in several tropical plants, are many times sweeter than sucrose on a molar basis. A good understanding of their structure–function relationship can complement traditional SAR studies on small molecular weight sweeteners and thus help in the design of safe sweeteners. However, there is virtually no sequence homology and very little structural similarity among known sweet proteins. Studies on mutants of monellin, the best characterized of sweet proteins, proved not decisive in the localization of the main interaction points of monellin with its receptor. Accordingly, we resorted to an unbiased approach to restrict the search of likely areas of interaction on the surface of a typical sweet protein. It has been recently shown that an accurate survey of the surface of proteins by appropriate paramagnetic probes may locate interaction points on protein surface. Here we report the survey of the surface of MNEI, a single chain monellin, by means of a paramagnetic probe, and a direct assessment of bound water based on an application of ePHOGSY, an NMR experiment that is ideally suited to detect interactions of small ligands to a protein. Detailed surface mapping reveals the presence, on the surface of MNEI, of interaction points that include residues previously predicted by ELISA tests and by mutagenesis.